Here are four insights:
1. The legislation is designed to ease FDA requirements.
2. The bills received bipartisan support.
3. Some opponents argue the legislation will prohibit the FDA from thoroughly inspecting the safety and efficacy of medical devices.
4. These bills are a piece of a larger National Institutes of Health initiative to increase medical research.
More articles on devices:
NuVasive receives Japanese approval for Reline posterior fixation technology: 5 notes
Nanovis wins NIH research grant for interbody fusion devices: 4 things to know
Wright Medical Group COO sells 13k+ shares: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
